Regeneron Announces Investor Conference Presentations

Rhea-AI Summary

Regeneron (NASDAQ: REGN) announced that it will webcast management presentations at three upcoming healthcare investor conferences in September 2026: the Wells Fargo Healthcare Conference on September 9 at 8:45 a.m. ET, the Morgan Stanley 24th Annual Global Healthcare Conference on September 14 at 1:05 p.m. ET, and the Bernstein Insights 3rd Annual Healthcare Forum on September 23 at 10:30 a.m. ET.

According to Regeneron, live webcasts, replays and transcripts will be available for at least 30 days on the "Investors & Media" section of its website.

Market Reaction – REGN

-0.96% $832.80

15m delay

-0.96% Vs previous close

$832.80 Last Price

$800.38 $844.92 Day Range

$85.74B Market Cap

1.1x Rel. Volume

Following this news, REGN has declined 0.96%, reflecting a mild negative market reaction. Our momentum scanner has triggered 10 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $832.80.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TARRYTOWN, N.Y., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

• 2026 Wells Fargo Healthcare Conference at 8:45 a.m. ET on Wednesday, September 9, 2026
  
• Morgan Stanley 24^th Annual Global Healthcare Conference at 1:05 p.m. ET on Monday, September 14, 2026
• Bernstein Insights: Healthcare Leaders and Disruptors – 3^rd Annual Healthcare Forum at 10:30 a.m. ET on Wednesday, September 23, 2026
  
  

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company's website for at least 30 days.

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. 

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite^®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center^® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.

Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com        

FAQ

When will Regeneron (NASDAQ: REGN) present at the 2026 Wells Fargo Healthcare Conference?

Regeneron will webcast its presentation at the 2026 Wells Fargo Healthcare Conference on September 9, 2026 at 8:45 a.m. ET. According to Regeneron, investors can access the live webcast via the company’s Investors & Media events and presentations webpage.

What time is Regeneron’s REGN presentation at the Morgan Stanley 24th Annual Global Healthcare Conference 2026?

Regeneron’s management will present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026 at 1:05 p.m. ET. According to Regeneron, the session will be available as a webcast through its Investors & Media events and presentations page.

When is Regeneron’s webcast at the Bernstein Insights 3rd Annual Healthcare Forum in September 2026?

Regeneron will participate in the Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum on September 23, 2026 at 10:30 a.m. ET. According to Regeneron, this session will be webcast and accessible from its investor relations website.

How can investors access the Regeneron (REGN) September 2026 conference webcasts?

Investors can access Regeneron’s September 2026 conference webcasts from the “Investors & Media” page on its website. According to Regeneron, the events are listed under the events and presentations section with links to the live streams.

Will replays of Regeneron’s 2026 investor conference webcasts be available for REGN shareholders?

Yes, replays and transcripts of Regeneron’s 2026 investor conference webcasts will be archived for at least 30 days. According to Regeneron, these materials will remain accessible through the company’s website after the live events conclude.

Where can I find transcripts of Regeneron’s September 2026 investor conference presentations?

Transcripts of Regeneron’s September 2026 investor conference webcasts will be available on the company’s website for at least 30 days. According to Regeneron, they are hosted in the Investors & Media events and presentations section alongside webcast replays.